29 August 2022

Amedeo Smart

Independent Medical Education


Subscriber: th..@boehringer-ingelheim.com

HIV Infection

29 August 2022 | n=17

  1. Lucas J, Lin LY, Paul N, Laumond G, et al.
    Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains.
    AIDS 2022.

  2. Jaschinski N, Greenberg L, Neesgaard B, Miro JM, et al.
    Recent abacavir use and incident cardiovascular disease in contemporary treated people living with HIV.
    AIDS 2022.

  3. Majonga ED, Yindom LM, Hameiri-Bowen D, Mayini J, et al.
    Proinflammatory and cardiovascular biomarkers are associated with echocardiographic abnormalities in children with HIV taking antiretroviral therapy.
    AIDS 2022.

  4. Deresinski S.
    A Nasty Human Immunodeficiency Virus Type 1 (HIV-1) Variant.
    Clin Infect Dis 2022;75:i-ii.

  5. Dirajlal-Fargo S, Zhao C, Labbato D, Sattar A, et al.
    Longitudinal changes in subclinical vascular disease in Ugandan youth with HIV.
    Clin Infect Dis 2022.

  6. Monin MB, Ingiliz P, Lutz T, Scholten S, et al.
    Low spontaneous clearance rates of recently acquired hepatitis C virus in HIV-positive MSM (The PROBE-C Study).
    Clin Infect Dis 2022.

  7. Kagujje M, Kerkhoff AD, Nteeni M, Dunn I, et al.
    The performance of computer-aided detection digital chest X-ray reading technologies for triage of active Tuberculosis among persons with a history of previous Tuberculosis.
    Clin Infect Dis 2022.

  8. Rowlinson E, Soge OO, Hughes JP, Berzkalns A, et al.
    Prior exposure to azithromycin and azithromycin resistance among persons diagnosed with Neisseria gonorrhoeae infection at a Sexual Health Clinic 2012-2019.
    Clin Infect Dis 2022.

  9. Masia M, Fernandez-Gonzalez M, Agullo V, Mascarell P, et al.
    HIV-1 RNA levels in rectal and seminal compartments after switching to long-acting cabotegravir plus rilpivirine: a longitudinal study.
    Clin Infect Dis 2022.

  10. Wake RM, Molloy SF, Jarvis JN, Harrison TS, et al.
    Cryptococcal Antigenemia in Advanced HIV: Pathophysiology, Epidemiology and Clinical Implications.
    Clin Infect Dis 2022.

  11. Singh P, Moulton LH, Barnes GL, Gupta A, et al.
    Pregnancy in Women with HIV in a Tuberculosis Preventive Therapy Trial.
    J Acquir Immune Defic Syndr 2022.

  12. Mathur P, Kottilil S, Pallikkuth S, Frasca D, et al.
    Persistent CD38 expression on CD8+ T lymphocytes contributes to altered mitochondrial function and chronic inflammation in people with HIV, despite ART.
    J Acquir Immune Defic Syndr 2022.

  13. Ghalekhani N, Bokaie S, Eybpoosh S, Akbarein H, et al.
    Reconstruction of molecular evolution of human influenza A H1N1/2009 virus in Iran and neighboring countries.
    J Med Virol 2022.

  14. Files JK, Sterrett S, Henostroza S, Fucile C, et al.
    HLA-II-Associated HIV-1 Adaptation Decreases CD4(+) T-Cell Responses in HIV-1 Vaccine Recipients.
    J Virol 2022.

  15. He X, Aid M, Ventura JD, Borducchi E, et al.
    Rapid Loss of CD4 T Cells by Pyroptosis during Acute SIV Infection in Rhesus Macaques.
    J Virol 2022.

  16. Gilbert PB, Huang Y, deCamp AC, Karuna S, et al.
    Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
    Nat Med 2022.

  17. Tanne JH.
    Anthony Fauci, medical adviser to seven US presidents, will leave office in December.
    BMJ 2022;378:o2084.


Display articles in


Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:



Amedeo HIV Infection

Five-Week Literature

22 April 2024

15 April 2024

08 April 2024

01 April 2024

25 March 2024


29 August 2022

Multidisciplinary Journal Club

  1. Mollenhauer B, von Arnim CAF.
    Toward preventing Parkinson's disease.
    Science. 2022;377:818-819.

  2. Roos I, Malpas C, Leray E, Casey R, et al.
    Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
    Neurology. 2022 Aug 17. pii: WNL.0000000000201029.

  3. Kirchgesner J, Desai RJ, Schneeweiss MC, Beaugerie L, et al.
    Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.
    Gut. 2022;71:1781-1789.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.


Privacy Policy